...
首页> 外文期刊>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology >Rapid anti-depressant and anxiolytic actions following dopamine D1-D2 receptor heteromer inactivation
【24h】

Rapid anti-depressant and anxiolytic actions following dopamine D1-D2 receptor heteromer inactivation

机译:多巴胺D1-D2受体异聚体失活后的快速抗抑郁和抗焦虑作用

获取原文
获取原文并翻译 | 示例

摘要

A role for the mesolimbic dopaminergic system in the pathophysiology of depression has become increasingly evident. Specifically, brain-derived neurotrophic factor (BDNF) has been shown to be elevated in the nucleus accumbens of depressed patients and to positively contribute to depression-like behaviour in rodents. The dopamine D1-D2 receptor heteromer exhibits significant expression in NAc and has also been shown to enhance BDNF expression and signalling in this region. We therefore examined the effects of D1-D2 heteromer stimulation in rats by SKF 83959, or its inactivation by a selective heteromer-disrupting TAT-D1 peptide on depression- and anxiety-like behaviours in non-stressed animals and in animals exposed to chronic unpredictable stress. SKF 83959 treatment significantly enhanced the latency to immobility in the forced swim test, increased the latency to drink condensed milk and reduced total milk consumption in the novelty-induced hypophagia test, and additionally reduced the total time spent in the open arms in the elevated plus maze test. These pro-depressant and anxiogenic effects of SKF 83959 were consistently abolished or attenuated by TAT-D1 peptide pre-treatment, signifying the behaviours were mediated by the D1-D2 heteromer. More importantly, in animals exposed to chronic unpredictable stress (CUS), TAT-D1 peptide treatment alone induced significant and rapid anxiolytic and antidepressant-like effects in two tests for CUS-induced anhedonia-like reactivity and in the novelty-suppressed feeding test. Together these findings indicate a positive role for the D1-D2 heteromer in mediating depression- and anxiety-like behaviours and suggest its possible value as a novel therapeutic target. (C) 2015 Elsevier B.V. and ECNR All rights reserved.
机译:中脑边缘多巴胺能系统在抑郁症的病理生理学中的作用越来越明显。具体而言,脑源性神经营养因子(BDNF)已显示在抑郁症患者的伏隔核中升高,并且对啮齿动物的抑郁症样行为有积极贡献。多巴胺D1-D2受体异聚体在NAc中表现出明显的表达,并且还显示出可以增强该区域中BDNF的表达和信号传导。因此,我们研究了SKF 83959对D1-D2异源单体刺激大鼠的作用,或通过选择性破坏异源单体的TAT-D1肽对未受压动物和暴露于慢性不可预测动物的抑郁和焦虑样行为的失活作用。强调。 SKF 83959治疗显着增加了强迫游泳测试中无法动弹的潜伏期,增加了饮用炼乳的潜伏期以及在新奇诱导的吞咽测试中减少了总的牛奶消费量,此外还减少了高架人群在张开双臂中花费的总时间迷宫测试。 TAT-D1肽预处理始终消除或减弱了SKF 83959的这些促抑郁和抗焦虑作用,表明其行为是由D1-D2异聚体介导的。更重要的是,在暴露于慢性不可预测压力(CUS)的动物中,单独的TAT-D1肽治疗在两项针对CUS引起的类似于性快感低下的反应性的试验中以及在抑制新颖性的喂养试验中,诱导了显着而快速的抗焦虑和抗抑郁样作用。这些发现共同表明D1-D2异聚体在介导抑郁和焦虑样行为中起积极作用,并暗示其作为新型治疗靶点的可能价值。 (C)2015 Elsevier B.V.和ECNR保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号